Portfolio Manager Factsheet

March 2016

Once again Ono Pharmaceutical continued momentum in the uptake of Opdivo. Allergan was weak due to investor concerns about the Pfizer deal.

Read more »

Register for email alerts

Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.